Charity profile · Historical source record

Israel Cancer Association USA

EIN 13-6218184HealthFloridaSmall

Historical collection: May 2019 · Rating details mostly from 2017. Source & context

The mission

What this organization describes

Supporting brilliant breakthroughs
Established in 1994, Israel Cancer Association USA (ICA USA) raises funds for the Israel Cancer Association. It has touched the lives of hundreds of thousands of cancer patients and their families in Israel by providing major funding to distinguished Israeli cancer researchers such as ICA. ICA is the leading and largest health-related charitable organization in Israel, and is in the forefront of the fight against cancer. It supports a vast array of important cancer research projects and services at 38 hospitals and universities throughout Israel without government funding.

Mission and tagline reproduced from the source record.

Historical scorecard

Three perspectives. One record.

96.66Overall score
out of 100
97.50Financial score
out of 100
96.00Accountability & transparency
out of 100

These are the dataset’s historical numeric fields, not a current rating or a new DonorAPI.com assessment. Read the score context ↗

Financial context

Revenue, expenses, and composition

Total revenue · USD$1,156,483
Total expenses · USD$826,326

Program expenses

$748,651.36 recorded amount
90.6%

Fundraising expenses

$35,532.02 recorded amount
4.3%

Administrative expenses

$40,489.97 recorded amount
4.9%
Fundraising efficiency
$0.04 spent per $1 raised in donations, as defined in the source.

Expense shares are displayed as percentages. Component amounts in this collection match total expenses multiplied by the source ratios; rounding can leave a small difference from the total. The source does not supply a row-specific fiscal year. Field definitions ↗

Historical leadership record

The leadership information supplied

Recorded leader
Julie Gordon
Recorded compensation
$50,000.00
Recorded compensation percentage
6.05%

These fields do not establish the current officeholder or current compensation. The metadata does not specify the denominator of the leader compensation percentage. Read with context ↗

Inspect all 23 original source fields

Exact source strings are retained below, including numeric precision. A blank value is marked as not reported; zero remains zero.

All 23 original fields for Israel Cancer Association USA
Source fieldOriginal source value
ascore
Accountability & transparency score
96.0
category
Category
Health
description
Mission & description
Established in 1994, Israel Cancer Association USA (ICA USA) raises funds for the Israel Cancer Association. It has touched the lives of hundreds of thousands of cancer patients and their families in Israel by providing major funding to distinguished Israeli cancer researchers such as ICA. ICA is the leading and largest health-related charitable organization in Israel, and is in the forefront of the fight against cancer. It supports a vast array of important cancer research projects and services at 38 hospitals and universities throughout Israel without government funding.
ein
EIN
13-6218184
tot_exp
Total expenses
826326.0
admin_exp_p
Administrative expense fraction
0.049
fund_eff
Fundraising efficiency ($ per $1 raised)
0.04
fund_exp_p
Fundraising expense fraction
0.043
program_exp_p
Program expense fraction
0.9059999999999999
fscore
Financial score
97.5
leader
Recorded leader
Julie Gordon
leader_comp
Recorded leader compensation
50000.0
leader_comp_p
Recorded leader compensation fraction
0.0605
motto
Tagline
Supporting brilliant breakthroughs
name
Charity name
Israel Cancer Association USA
tot_rev
Total revenue
1156483.0
score
Overall score
96.66
state
State code
FL
subcategory
Subcategory
Medical Research
size
Source size label
small
program_exp
Program expenses
748651.3559999999
fund_exp
Fundraising expenses
35532.018
admin_exp
Administrative expenses
40489.974

Source: Charity Navigator Scores Expenses Dataset, version 1, attributed to katyjqian on Kaggle. Collection: May 2019; rating details mostly from 2017. Read attribution, scope, and reuse notes.